These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7672425)

  • 1. Expression of gelatinolytic activity by oesophageal and colon carcinoma cell lines.
    Della Porta P; Ryan NM; Collins KJ
    Biochem Soc Trans; 1995 May; 23(2):391S. PubMed ID: 7672425
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.
    Karakiulakis G; Papanikolaou C; Jankovic SM; Aletras A; Papakonstantinou E; Vretou E; Mirtsou-Fidani V
    Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
    Kugler A; Hemmerlein B; Thelen P; Kallerhoff M; Radzun HJ; Ringert RH
    J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, T.Tn expressing non-functional mutated p53.
    Sakai T; Furihata T; Kawamata H; Omotehara F; Shinagawa Y; Imura J; Kubota K; Terano A; Fujimori T
    Int J Oncol; 2002 Sep; 21(3):547-52. PubMed ID: 12168098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
    Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
    J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
    Tsukifuji R; Tagawa K; Hatamochi A; Shinkai H
    Br J Cancer; 1999 Jun; 80(7):1087-91. PubMed ID: 10362121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 modulates the expression of gelatinase A and B in monocytic cells.
    Kalebic T; Masiero L; Onisto M; Garbisa S
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1243-9. PubMed ID: 7802656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis.
    Kawamata H; Uchida D; Hamano H; Kimura-Yanagawa T; Nakashiro KI; Hino S; Omotehara F; Yoshida H; Sato M
    Int J Oncol; 1998 Oct; 13(4):699-704. PubMed ID: 9735398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M; Fudge K; Rhim JS; Stearns ME
    Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.
    Fang KC; Wolters PJ; Steinhoff M; Bidgol A; Blount JL; Caughey GH
    J Immunol; 1999 May; 162(9):5528-35. PubMed ID: 10228034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
    Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
    Sehgal I; Thompson TC
    Cancer Res; 1998 Oct; 58(19):4288-91. PubMed ID: 9766654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
    Shima I; Sasaguri Y; Kusukawa J; Nakano R; Yamana H; Fujita H; Kakegawa T; Morimatsu M
    Br J Cancer; 1993 Apr; 67(4):721-7. PubMed ID: 8471429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.